(Q37750519)

22 August 2017

1 reference

title

Development and use of FRAX in osteoporosis (English)

1 reference

22 August 2017

0 references

J A Kanis

1

1 reference

22 August 2017

E V McCloskey

2

1 reference

22 August 2017

H Johansson

3

1 reference

22 August 2017

A Oden

4

1 reference

22 August 2017

O Ström

5

1 reference

22 August 2017

F Borgström

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 May 2010

1 reference

Osteoporosis International

22 August 2017

published in

1 reference

22 August 2017

volume

21 Suppl 2

1 reference

22 August 2017

page(s)

S407-13

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-010-1253-y

22 August 2017

exact match

0 references

cites work

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-010-1253-Y

International variations in hip fracture probabilities: implications for risk assessment

21 January 2018

1 reference

12 December 2020

FRAX assessment of osteoporotic fracture probability in Switzerland

1 reference

12 December 2020

A family history of fracture and fracture risk: a meta-analysis.

1 reference

12 December 2020

Diagnosis of osteoporosis and assessment of fracture risk

1 reference

12 December 2020

Alcohol intake as a risk factor for fracture

1 reference

12 December 2020

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX)

1 reference

12 December 2020

Body mass index as a predictor of fracture risk: a meta-analysis.

1 reference

12 December 2020

Smoking and fracture risk: a meta-analysis

1 reference

12 December 2020

Assessment of fracture risk

1 reference

12 December 2020

[A FRAX model for the assessment of fracture probability in Belgium]

1 reference

12 December 2020

A meta-analysis of previous fracture and subsequent fracture risk

1 reference

12 December 2020

[Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006]

1 reference

12 December 2020

Requirements for DXA for the management of osteoporosis in Europe

1 reference

12 December 2020

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

1 reference

12 December 2020

Ten-year fracture probability identifies women who will benefit from clodronate therapy--additional results from a double-blind, placebo-controlled randomised study

1 reference

12 December 2020

A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk

1 reference

12 December 2020

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

1 reference

12 December 2020

A New Approach to the Development of Assessment Guidelines for Osteoporosis

1 reference

12 December 2020

Long-term risk of osteoporotic fracture in Malmö.

1 reference

12 December 2020

Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application

1 reference

12 December 2020

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

1 reference

12 December 2020

Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation.

1 reference

12 December 2020

Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores

1 reference

12 December 2020

Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment

1 reference

12 December 2020

Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds

1 reference

12 December 2020

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

1 reference

12 December 2020

The cost-effectiveness of alendronate in the management of osteoporosis

1 reference

12 December 2020

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.

1 reference

12 December 2020

Adverse outcomes of osteoporotic fractures in the general population

1 reference

12 December 2020

Cost-effective osteoporosis treatment thresholds: the United States perspective

1 reference

12 December 2020

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

1 reference

12 December 2020

Age and bone mass as predictors of fracture in a prospective study

1 reference

12 December 2020

10.1007/S00198-010-1253-Y

Identifiers

DOI

1 reference

release_q22gpc6jkfgwdngryzmjew5ede

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q22gpc6jkfgwdngryzmjew5ede

24 November 2022

mapped directly with Wikidata item

1 reference